HRT Financial’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-177,780
Closed -$7.48M – 4693
2026
Q2
$7.48M Buy
177,780
+153,646
+637% +$4.89M 0.01% 923
2026
Q1
$637K Buy
+24,134
New +$707K ﹤0.01% 2341
2025
Q2
– Sell
-18,626
Closed -$386K – 2567
2025
Q1
$386K Buy
+18,626
New +$468K ﹤0.01% 1632
2024
Q4
– Sell
-221,698
Closed -$5.68M – 2404
2024
Q3
$5.68M Buy
221,698
+121,179
+121% +$3.09M 0.03% 408
2024
Q2
$2.36M Buy
+100,519
New +$2.54M 0.01% 666
2023
Q2
– Sell
-20,047
Closed -$602K – 2434
2023
Q1
$602K Sell
20,047
-7,730
-28% -$240K 0.01% 1240
2022
Q4
$784K Buy
+27,777
New +$882K 0.01% 1113
2022
Q3
– Sell
-78,061
Closed -$2.46M – 2759
2022
Q2
$2.46M Sell
78,061
-76,985
-50% -$2.69M 0.03% 488
2022
Q1
$7.12M Buy
155,046
+143,344
+1,225% +$6.83M 0.05% 201
2021
Q4
$716K Sell
11,702
-165,873
-93% -$11.5M ﹤0.01% 1484
2021
Q3
$13.3M Sell
177,575
-185,018
-51% -$15.5M 0.08% 119
2021
Q2
$33.5M Buy
+362,593
New +$30.8M 0.31% 46
2021
Q1
– Sell
-149,385
Closed -$13.9M – 2666
2020
Q4
$13.9M Buy
+149,385
New +$11.9M 0.28% 60

Other funds holding ARKG

HRT Financial's ARKG Position: Q3 2026 in Review

HRT Financial sold out of ARK Genomic Revolution ETF (ARKG) in Q3 2026, closing a stake of 177,780 shares — an estimated $7.48M sold.

HRT Financial first reported a position in ARKG in Q4 2020 and held it in 13 quarters. The position peaked at $33.5M in Q2 2021. 316 funds tracked by Wall St. Rank hold ARKG as of Q3 2026.

  • HRT Financial reported no remaining ARK Genomic Revolution ETF position as of Q3 2026 after selling out during the quarter.
  • HRT Financial sold 177,780 ARK Genomic Revolution ETF shares in Q3 2026, an estimated $7.48M.
  • HRT Financial first reported a position in ARK Genomic Revolution ETF in Q4 2020 and held it in 13 quarters.
  • HRT Financial's ARK Genomic Revolution ETF position peaked at $33.5M in Q2 2021.
  • 316 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q3 2026.

Based on HRT Financial's 13F filing for Q3 2026, filed 13 Nov 2026.